WO2004005492A3 - Probiotic compound on the basis of enterococcus faecium strain l-3 for medical-prophylactic means and method of production thereof - Google Patents

Probiotic compound on the basis of enterococcus faecium strain l-3 for medical-prophylactic means and method of production thereof Download PDF

Info

Publication number
WO2004005492A3
WO2004005492A3 PCT/RU2003/000039 RU0300039W WO2004005492A3 WO 2004005492 A3 WO2004005492 A3 WO 2004005492A3 RU 0300039 W RU0300039 W RU 0300039W WO 2004005492 A3 WO2004005492 A3 WO 2004005492A3
Authority
WO
WIPO (PCT)
Prior art keywords
probiotic composition
inventive
enterococcus
medical
skin
Prior art date
Application number
PCT/RU2003/000039
Other languages
French (fr)
Russian (ru)
Other versions
WO2004005492A2 (en
Inventor
Galina Gennadievna Alekhina
Alexander Nickolaevich Suvorov
Original Assignee
Galina Gennadievna Alekhina
Alexander Nickolaevich Suvorov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2002118758A external-priority patent/RU2220199C1/en
Priority claimed from RU2002118757/15A external-priority patent/RU2227039C2/en
Application filed by Galina Gennadievna Alekhina, Alexander Nickolaevich Suvorov filed Critical Galina Gennadievna Alekhina
Priority to AU2003211648A priority Critical patent/AU2003211648A1/en
Publication of WO2004005492A2 publication Critical patent/WO2004005492A2/en
Publication of WO2004005492A3 publication Critical patent/WO2004005492A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The inventive probiotic composition based on the enterococcus strain relates to novel treatment means for preventing and curing bacterial and viral infections and dysbacteriosis of mucosa and skin and can be used for pharmacology, medicine and cosmetology. Said invention also relates to microbiology, in particular to the strains of the bacteria-enterococcus used in medical and food biotechnology. Said strains exhibit high-adhesive properties and pronounced antagonistic properties with respect to gram-negative coliform bacteria and gram-positive bacteria and fungus and also resistance to the action of extremal factors. The invention can be carried out in any region of the globe using acting pharmacological and food productions and microbiological and biotechnological laboratories . The production of the probiotic composition is ecologically safe and low waste. The inventive method consists in producing a probiotic composition based on a separated enterococcus strain and having a high antagonistic activity in relation to opportunistic and pathogenic microflora, and used for treatment means and curative food products. The invention, whose feasibility is proved by many clinical and laboratory tests, ensures the high efficiency of the inventive probiotic composition for preventing and curing various skin and mucosa inflammatory processes. The invention is successfully used for cosmetology and dermatology in the form of skin patches, cosmetic masks, medicinal powders, external ointments, and also for gastroenterology in the form of pills and pastilles for stomach, intestines, oral mucosa etc. The inventive method for producing the probiotic composition is universal, reliable and ecologically safe.
PCT/RU2003/000039 2002-07-03 2003-02-06 Probiotic compound on the basis of enterococcus faecium strain l-3 for medical-prophylactic means and method of production thereof WO2004005492A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003211648A AU2003211648A1 (en) 2002-07-03 2003-02-06 Probiotic compound on the basis of enterococcus faecium strain l-3 for medical-prophylactic means and method of production thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
RU2002118758A RU2220199C1 (en) 2002-07-03 2002-07-03 Enterococcus strain enterococcus faecium l-3 for preparing curative-prophylactic agents and foodstuffs of curative-prophylactic designation
RU2002118757 2002-07-03
RU2002118758 2002-07-03
RU2002118757/15A RU2227039C2 (en) 2002-07-03 2002-07-03 Probiotic composition with high antagonistic activity with respect to opportunistic and pathogenic microflora for curative-prophylactic agents and method for its preparing

Publications (2)

Publication Number Publication Date
WO2004005492A2 WO2004005492A2 (en) 2004-01-15
WO2004005492A3 true WO2004005492A3 (en) 2004-11-04

Family

ID=30117573

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2003/000039 WO2004005492A2 (en) 2002-07-03 2003-02-06 Probiotic compound on the basis of enterococcus faecium strain l-3 for medical-prophylactic means and method of production thereof

Country Status (2)

Country Link
AU (1) AU2003211648A1 (en)
WO (1) WO2004005492A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2021457B1 (en) * 2006-05-28 2015-02-11 Cipla Medpro Research And Development (Pty) Ltd Probiotic strain and antimicrobial peptide derived therefrom
WO2008094065A1 (en) * 2007-02-02 2008-08-07 Alexei Nikolaevich Parfenov METHOD AND A THERAPEUTIC AGENT WHICH IS USED FOR TREATING VIRAL HEPATITIS AND BASED ON Enterococcus Faecium M (VKPM B-3490) AND Enterococcus faecium M-3185 (VKPM B- 3491) STRAINS
CN112608858A (en) * 2020-12-17 2021-04-06 上海交大昂立股份有限公司 Probiotic composition with freckle removing effect and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1043194A (en) * 1962-04-13 1966-09-21 Alfred Bird & Sons Ltd Dehydrated fermented milk products
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
EP0953289A2 (en) * 1998-04-08 1999-11-03 Protein Technologies International, Inc. High fat and high protein content milk replacer and process for its production
RU2142504C1 (en) * 1999-02-16 1999-12-10 Хомичева Светлана Яковлевна Method of preparing biologically active addition as dried form containing bacteria-eubiotics and filling for bread and confectionery articles based on said
EP1082964A1 (en) * 1998-06-05 2001-03-14 Wakamoto Pharmaceutical Co., Ltd. Lactic acid bacterium-containing compositions, drugs and foods
EP1133991A1 (en) * 1998-11-26 2001-09-19 Meito Sangyo Kabushiki Kaisha Bacteriostatic compositions for salmonellae

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1043194A (en) * 1962-04-13 1966-09-21 Alfred Bird & Sons Ltd Dehydrated fermented milk products
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
EP0953289A2 (en) * 1998-04-08 1999-11-03 Protein Technologies International, Inc. High fat and high protein content milk replacer and process for its production
EP1082964A1 (en) * 1998-06-05 2001-03-14 Wakamoto Pharmaceutical Co., Ltd. Lactic acid bacterium-containing compositions, drugs and foods
EP1133991A1 (en) * 1998-11-26 2001-09-19 Meito Sangyo Kabushiki Kaisha Bacteriostatic compositions for salmonellae
RU2142504C1 (en) * 1999-02-16 1999-12-10 Хомичева Светлана Яковлевна Method of preparing biologically active addition as dried form containing bacteria-eubiotics and filling for bread and confectionery articles based on said

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CASAUS PILAR ET AL: "Enterocin B, a new bacteriocin from Enterococcus faecium T136 which can act synergistically with enterocin A", MICROBIOLOGY (READING), vol. 143, no. 7, 1997, pages 2287 - 2294, XP002257062, ISSN: 1350-0872 *
DATABASE WPI Section Ch Week 200045, Derwent World Patents Index; Class D11, AN 2000-504687, XP002282423 *
ENNAHAR SAID ET AL: "Biochemical and genetic evidence for production of enterocins A and B by Enterococcus faecium WHE 81", INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, vol. 70, no. 3, 8 November 2001 (2001-11-08), pages 291 - 301, XP002257063, ISSN: 0168-1605 *
TO B C S ET AL: "SURVIVAL OF BREVIBACTERIUM LINENS (ATCC 9174) AFTER SPRAY DRYING, FREEZE DRYING, OR FREEZING", JOURNAL OF FOOD SCIENCE, INSTITUTE OF FOOD TECHNOLOGISTS. CHICAGO, US, vol. 62, no. 1, 1997, pages 167 - 171, XP002038915, ISSN: 0022-1147 *

Also Published As

Publication number Publication date
AU2003211648A8 (en) 2004-01-23
AU2003211648A1 (en) 2004-01-23
WO2004005492A2 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
Mastromarino et al. Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets
Liu et al. Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis
SE0402406D0 (en) Probiotic lactobacillus strains for improved vaginal health
MY172685A (en) A lactobacillus crispatus and application thereof
RU2010142489A (en) STRAIN LACTOBACILLUS RHAMNOSUS
BR112013019258A8 (en) USE OF A PROBIOTICAL FORMULATION COMPRISING A STRAIN OF BIFIDOBACTERIUM BIFIDUM
DK2555785T3 (en) Use of Streptococcus salivarius in the treatment of chronic respiratory tract infections
EP4107293B1 (en) Cutibacterium acnes strain and medical uses thereof
Paniagua-Contreras et al. Comprehensive expression analysis of pathogenicity genes in uropathogenic Escherichia coli strains
JP2017519730A5 (en)
De Keukeleire et al. Yersinia ruckeri, an unusual microorganism isolated from a human wound infection
DK1624762T3 (en) Probiotic composition with at least two lactic acid bacterial strains capable of colonizing the gastrointestinal tract, in combination with their survival, intestinal-binding, infection-protecting and fiber-fermenting properties
WO2004005492A3 (en) Probiotic compound on the basis of enterococcus faecium strain l-3 for medical-prophylactic means and method of production thereof
Molazade et al. Evaluation of Antibiotic Resistance Pattern of Isolated Gram-Negative Bacteria from Urine Culture of Hospitalized patients in Different Wards of Vali-Asr Hospital in Fasa During the Years 2012 and 2013.
Sharma et al. Inhibition of Pseudomonas aeruginosa by antibiotics and probiotics combinations-In vitro study
Jain et al. Globicatella sanguinis meningitis in a post head trauma patient: first case report from Asia
Choo et al. Soy fermentation by orally isolated putative probiotic Streptococcus salivarius for healthy oral
ATE466023T1 (en) MANNOSE-SPECIFIC ADHESINS AND THEIR USE
RU2570622C2 (en) Lactobacillus rhamnosus strain, POSSESSING ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY AGAINST PATHOGENIC AND OPPORTUNISTIC VAGINAL MICROFLORA
How et al. Development of indigenous Streptococcus salivarius TUCC 1253-fermented soy oral strip using Box-Behnken design for oral health
RU2220199C1 (en) Enterococcus strain enterococcus faecium l-3 for preparing curative-prophylactic agents and foodstuffs of curative-prophylactic designation
Suvorov et al. Enterococci as probiotics or autoprobiotics in treatment of the gastrointestinal diseases
Etebarian et al. Oral Lactobacillus species and their probiotic capabilities in patients with periodontitis and periodontally healthy individuals
EA201501069A1 (en) SYNBIOTIC COMPOSITION FOR CORRECTION OF DISBIOTIC DISORDERS OF MICROBIOCENOSIS OF GASTROINTESTINAL TRACT
Shaprynskyi et al. SPECIFIC ASPECTS IN TREATMENT OF SUPPURATIVE-INFLAMMATORY COMPLICATIONS IN GUNSHOT WOUNDS OF EXTREMITIES

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AM AT AU AZ BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IN IS JP KE KG KP KR KZ LK LT LU LV MD MN MX NO NZ PL PT RO RU SE SG SK TJ TM TR UA US UZ VN ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP